Recent discussions on X about Amrize Ltd (AMRZ) have been lively, primarily driven by the company's Q2 2025 earnings report, which fell short of analyst expectations. Many users have pointed out the subsequent drop in stock price, raising concerns about the company's near-term performance. The conversation is buzzing with speculation on whether strategic acquisitions and cost controls can turn things around.
Adding to the discourse, significant insider buying activity has caught the attention of the X community, with some interpreting it as a strong signal of confidence from within the company. Others remain skeptical, questioning if this move can offset the disappointing earnings. The mix of opinions keeps the dialogue engaging as investors weigh the risks and potential rewards.
Note: This discussion summary was generated from an AI condensation of post data.
Amrize Ltd Insider Trading Activity
Amrize Ltd insiders have traded $AMRZ stock on the open market 50 times in the past 6 months. Of those trades, 50 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AMRZ stock by insiders over the last 6 months:
- JAN PHILIPP JENISCH (Chairman & CEO) has made 14 purchases buying 1,095,000 shares for an estimated $51,793,745 and 0 sales.
- MARIO GROSS (Chief Supply Chain Officer) has made 3 purchases buying 10,600 shares for an estimated $506,940 and 0 sales.
- IAN A JOHNSTON (Chief Financial Officer) has made 12 purchases buying 10,500 shares for an estimated $500,986 and 0 sales.
- JAIME HILL (President, Building Materials) has made 3 purchases buying 8,500 shares for an estimated $418,372 and 0 sales.
- STEPHEN S CLARK (Chief People Officer) has made 11 purchases buying 5,000 shares for an estimated $259,122 and 0 sales.
- ROALD BROUWER (Chief Technology Officer) has made 5 purchases buying 5,000 shares for an estimated $244,927 and 0 sales.
- DENISE R SINGLETON (Chief Legal Officer & Corp Sec) purchased 4,000 shares for an estimated $190,560
- SAMUEL JONAS POLETTI (Chief Strategy & M&A Officer) purchased 1,280 shares for an estimated $59,161
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Amrize Ltd Analyst Ratings
Wall Street analysts have issued reports on $AMRZ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 08/26/2025
- RBC Capital issued a "Outperform" rating on 08/08/2025
- Truist Securities issued a "Buy" rating on 06/24/2025
- Morgan Stanley issued a "Overweight" rating on 06/24/2025
To track analyst ratings and price targets for Amrize Ltd, check out Quiver Quantitative's $AMRZ forecast page.
Amrize Ltd Price Targets
Multiple analysts have issued price targets for $AMRZ recently. We have seen 8 analysts offer price targets for $AMRZ in the last 6 months, with a median target of $58.5.
Here are some recent targets:
- Adrian Huerta from JP Morgan set a target price of $60.0 on 08/26/2025
- Anthony Codling from RBC Capital set a target price of $54.0 on 08/08/2025
- Pujarini Ghosh from Bernstein set a target price of $62.0 on 07/10/2025
- Jerry Revich from Goldman Sachs set a target price of $57.0 on 07/01/2025
- Arnaud Lehmann from B of A Securities set a target price of $56.0 on 06/26/2025
- Keith Hughes from Truist Securities set a target price of $60.0 on 06/24/2025
- Cedar Ekblom from Morgan Stanley set a target price of $62.0 on 06/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
